<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a <z:hpo ids='HP_0011010'>chronic</z:hpo>, relapsing, systemic <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> characterized by recurrent oral and <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>, <z:mp ids='MP_0001212'>skin lesions</z:mp>, and ocular lesions </plain></SENT>
<SENT sid="1" pm="."><plain>Gastrointestinal tract is occasionally involved in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, and the typical gastrointestinal lesions are punched-out, discrete mucosal ulcerations </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi>, <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> derivatives, thalidomide, and immunomodulators have been used to treat <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="3" pm="."><plain>Some patients with gastrointestinal <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease undergo surgical management because of the refractoriness to these medical measures or complications, such as <z:mpath ids='MPATH_81'>perforation</z:mpath> and <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Even after successful surgery, postoperative complications, such as poor healing of the anastomosis site and postoperative <z:mpath ids='MPATH_579'>ulcer</z:mpath> recurrence, are so common that repeated operations are frequently required </plain></SENT>
<SENT sid="5" pm="."><plain>However, there have been few reports addressing the most effective way to reduce and treat postoperative complications and recurrences </plain></SENT>
<SENT sid="6" pm="."><plain>We describe a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease involving the distal ileum, who was treated with infliximab as rescue therapy of an unhealed anastomosis site and early recurrent <z:mpath ids='MPATH_579'>ulcers</z:mpath> after a distal ileocecectomy because of persistent <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0002027'>Abdominal pain</z:hpo> from recurrent <z:mpath ids='MPATH_579'>ulcers</z:mpath> improved by the fifth day after the infliximab infusion and almost disappeared by the second week </plain></SENT>
<SENT sid="8" pm="."><plain>An ileocolonoscopy performed 15 days after the infliximab infusion showed near complete healing of the recurrent <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>This report suggests that infliximab may be an effective novel therapy for the management of early postoperative complications and recurrences in gastrointestinal <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>